These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 29197967)

  • 1. Effects of nutraceuticals on anaplastic thyroid cancer cells.
    Allegri L; Rosignolo F; Mio C; Filetti S; Baldan F; Damante G
    J Cancer Res Clin Oncol; 2018 Feb; 144(2):285-294. PubMed ID: 29197967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BET bromodomain inhibitor JQ1 modulates microRNA expression in thyroid cancer cells.
    Mio C; Conzatti K; Baldan F; Allegri L; Sponziello M; Rosignolo F; Russo D; Filetti S; Damante G
    Oncol Rep; 2018 Feb; 39(2):582-588. PubMed ID: 29251329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Krüppel-Like Factor 4 in the Maintenance of Chemoresistance of Anaplastic Thyroid Cancer.
    Lee SI; Kim DK; Seo EJ; Choi EJ; Kwon YW; Jang IH; Lee JC; Kim HY; Shong M; Kim JH; Kim SJ
    Thyroid; 2017 Nov; 27(11):1424-1432. PubMed ID: 28920531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Cancer Stem-Like Phenotype by Curcumin and Deguelin in CAL-62 Anaplastic Thyroid Cancer Cells.
    Kocdor MA; Cengiz H; Ates H; Kocdor H
    Anticancer Agents Med Chem; 2019; 19(15):1887-1898. PubMed ID: 31584382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of HCP5 exerts tumor-suppressive functions by up-regulating tumor suppressor miR-128-3p in anaplastic thyroid cancer.
    Chen J; Zhao D; Meng Q
    Biomed Pharmacother; 2019 Aug; 116():108966. PubMed ID: 31102936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcript-level regulation of MALAT1-mediated cell cycle and apoptosis genes using dual MEK/Aurora kinase inhibitor "BI-847325" on anaplastic thyroid carcinoma.
    Samimi H; Haghpanah V; Irani S; Arefian E; Sohi AN; Fallah P; Soleimani M
    Daru; 2019 Jun; 27(1):1-7. PubMed ID: 31077090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antisense-miR-21 enhances differentiation/apoptosis and reduces cancer stemness state on anaplastic thyroid cancer.
    Haghpanah V; Fallah P; Tavakoli R; Naderi M; Samimi H; Soleimani M; Larijani B
    Tumour Biol; 2016 Jan; 37(1):1299-308. PubMed ID: 26289851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigallocatechin-3-gallate induces growth inhibition and apoptosis of human anaplastic thyroid carcinoma cells through suppression of EGFR/ERK pathway and cyclin B1/CDK1 complex.
    Lim YC; Cha YY
    J Surg Oncol; 2011 Dec; 104(7):776-80. PubMed ID: 21725973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-148a inhibits self-renewal of thyroid cancer stem cells via repressing INO80 expression.
    Sheng W; Chen Y; Gong Y; Dong T; Zhang B; Gao W
    Oncol Rep; 2016 Dec; 36(6):3387-3396. PubMed ID: 27779717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TWIST1/miR-584/TUSC2 pathway induces resistance to apoptosis in thyroid cancer cells.
    Orlandella FM; Di Maro G; Ugolini C; Basolo F; Salvatore G
    Oncotarget; 2016 Oct; 7(43):70575-70588. PubMed ID: 27661106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selumetinib Activity in Thyroid Cancer Cells: Modulation of Sodium Iodide Symporter and Associated miRNAs.
    Wächter S; Wunderlich A; Greene BH; Roth S; Elxnat M; Fellinger SA; Verburg FA; Luster M; Bartsch DK; Di Fazio P
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30018229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of BP-14, a novel cyclin-dependent kinase inhibitor, on anaplastic thyroid cancer cells.
    Allegri L; Baldan F; Mio C; Puppin C; Russo D; Kryštof V; Damante G
    Oncol Rep; 2016 Apr; 35(4):2413-8. PubMed ID: 26884249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nobiletin Alone or in Combination with Cisplatin Decreases the Viability of Anaplastic Thyroid Cancer Cell Lines.
    Sousa DP; Pojo M; Pinto AT; Leite V; Serra AT; Cavaco BM
    Nutr Cancer; 2020; 72(2):352-363. PubMed ID: 31287730
    [No Abstract]   [Full Text] [Related]  

  • 14. Resveratrol induces differentiation markers expression in anaplastic thyroid carcinoma via activation of Notch1 signaling and suppresses cell growth.
    Yu XM; Jaskula-Sztul R; Ahmed K; Harrison AD; Kunnimalaiyaan M; Chen H
    Mol Cancer Ther; 2013 Jul; 12(7):1276-87. PubMed ID: 23594881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of miR-144 on the sensitivity of human anaplastic thyroid carcinoma cells to cisplatin by autophagy regulation.
    Liu J; Feng L; Zhang H; Zhang J; Zhang Y; Li S; Qin L; Yang Z; Xiong J
    Cancer Biol Ther; 2018 Jun; 19(6):484-496. PubMed ID: 29504819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-381-3p attenuates doxorubicin resistance in human anaplastic thyroid carcinoma via targeting homeobox A9.
    Zhang Y; Li K; Wang W; Han J
    Int J Exp Pathol; 2021 Aug; 102(4-5):209-217. PubMed ID: 34719830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor Effect of Various Phytochemicals on Diverse Types of Thyroid Cancers.
    Shin HJ; Hwang KA; Choi KC
    Nutrients; 2019 Jan; 11(1):. PubMed ID: 30634497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of Epigallocatechin-3-gallate and Dabrafenib combination on apoptosis and the genes involved in epigenetic events in anaplastic thyroid cancer cells.
    Birden N; Selvi Gunel N; Ozates NP; Goker Bagca B; Gunduz C; Sabour Takanlou L; Sabour Takanlou M; Biray Avci C
    Med Oncol; 2022 May; 39(5):98. PubMed ID: 35599263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the Highly Expressed microRNA miR-146b with CRISPR/Cas9n Gene Editing System in Thyroid Cancer.
    Santa-Inez DC; Fuziwara CS; Saito KC; Kimura ET
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-125b inhibits anaplastic thyroid cancer cell migration and invasion by targeting PIK3CD.
    Bu Q; You F; Pan G; Yuan Q; Cui T; Hao L; Zhang J
    Biomed Pharmacother; 2017 Apr; 88():443-448. PubMed ID: 28122310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.